chrX-18579965-C-T

Variant summary

Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_001323289.2(CDKL5):​c.400C>T​(p.Arg134*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: not found (cov: 23)

Consequence

CDKL5
NM_001323289.2 stop_gained

Scores

4
1
5

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:5

Conservation

PhyloP100: 2.27

Publications

11 publications found
Variant links:
Genes affected
CDKL5 (HGNC:11411): (cyclin dependent kinase like 5) This gene is a member of Ser/Thr protein kinase family and encodes a phosphorylated protein with protein kinase activity. Mutations in this gene have been associated with X-linked infantile spasm syndrome (ISSX), also known as X-linked West syndrome, and Rett syndrome (RTT). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]
CDKL5 Gene-Disease associations (from GenCC):
  • CDKL5 disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 2
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • atypical Rett syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • precocious puberty
    Inheritance: XL Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 18 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant X-18579965-C-T is Pathogenic according to our data. Variant chrX-18579965-C-T is described in ClinVar as Pathogenic. ClinVar VariationId is 143820.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDKL5NM_001323289.2 linkc.400C>T p.Arg134* stop_gained Exon 6 of 18 ENST00000623535.2 NP_001310218.1
CDKL5NM_001037343.2 linkc.400C>T p.Arg134* stop_gained Exon 7 of 22 NP_001032420.1
CDKL5NM_003159.3 linkc.400C>T p.Arg134* stop_gained Exon 6 of 21 NP_003150.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDKL5ENST00000623535.2 linkc.400C>T p.Arg134* stop_gained Exon 6 of 18 1 NM_001323289.2 ENSP00000485244.1

Frequencies

GnomAD3 genomes
Cov.:
23
GnomAD4 exome
Cov.:
26
GnomAD4 genome
Cov.:
23
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Developmental and epileptic encephalopathy, 2 Pathogenic:2
Mar 24, 2025
Institute of Human Genetics, University of Leipzig Medical Center
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Criteria applied: PVS1,PS2,PS4,PM2_SUP

Mar 13, 2014
RettBASE
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:curation

CDKL5 disorder Pathogenic:1
Jul 16, 2024
Centre for Population Genomics, CPG
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:curation

This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as pathogenic. At least the following criteria are met: Predicted to result in loss of function, and LOF is a known mechanism of disease (PVS1). This variant is absent from gnomAD (PM2_Supporting). Has been observed in at least 2 individuals with phenotypes consistent with CDKL5 disorder (PS4_Supporting, PMIDs: 21318334, 27334371).

not provided Pathogenic:1
Apr 23, 2024
GeneDx
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Identified in patients with CDKL5-related disorders in published literature (PMID: 25657822, 21318334); Identified in patients with features of a CDKL5-related disorder referred for genetic testing at GeneDx, including as an apparently de novo variant or a mosaic variant in multiple cases; Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 22678952, 21318334, 22670135, 28837158, 25525159, 27334371, 23064044, 30898514, 30776697, 31232219, 35483386, 35978140, 22872100, 31313283, 33047306, 25657822)

Developmental and epileptic encephalopathy, 2;CN128785:Angelman syndrome-like Pathogenic:1
Sep 23, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change creates a premature translational stop signal (p.Arg134*) in the CDKL5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CDKL5 are known to be pathogenic (PMID: 22872100). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of CDKL5-related conditions (PMID: 21318334, 27334371). In at least one individual the variant was observed to be de novo. This variant is also known as chrX:18598085:C/T. ClinVar contains an entry for this variant (Variation ID: 143820). For these reasons, this variant has been classified as Pathogenic.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.57
D
BayesDel_noAF
Pathogenic
0.58
CADD
Pathogenic
35
DANN
Uncertain
1.0
DEOGEN2
Benign
0.0
.;.;.;.;.;.
LIST_S2
Benign
0.0
.;.;.;.;.;.
MetaRNN
Benign
0.0
.;.;.;.;.;.
MutationAssessor
Benign
0.0
.;.;.;.;.;.
PhyloP100
2.3
PROVEAN
Benign
0.0
.;.;.;.;.;.
Sift
Pathogenic
0.0
.;.;.;.;.;.
Sift4G
Pathogenic
0.0
.;.;.;.;.;.
Vest4
0.95
GERP RS
-0.78
Mutation Taster
=0/200
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs267608472; hg19: chrX-18598085; API